Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

This streamlined approach not only accelerates the drug discovery pipeline but also improves the overall success rate of identifying viable drug targets. The AI-Powered Target Identification Service ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform.

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

The collaboration, highlighted at NVIDIA's GTC conference, aims to integrate artificial intelligence into surgical robotics, potentially enhancing Stereotaxis' technological capabilities.

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...